TY - JOUR AU - Chen, Chaojiang AU - Cai, Zhiduan AU - Zhuo, Yangjia AU - Xi, Ming AU - Lin, Zhuoyuan AU - Jiang, Funeng AU - Liu, Zezhen AU - Wan, Yueping AU - Zheng, Yu AU - Li, Jianxin AU - Zhou, Xing AU - Zhu, Jianguo AU - Zhong, Weide PY - 2020 DA - 2020/04/06 TI - Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer JO - BMC Cancer SP - 289 VL - 20 IS - 1 AB - Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to investigate the expression and clinical significance of SLC6A1 in PCa tissues and its effect on drug resistance to docetaxel in PCa. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-020-06776-7 DO - 10.1186/s12885-020-06776-7 ID - Chen2020 ER -